Description

Contraindicated in patients who develop hypersensitivity reactions or chemical intolerance to Trifluridine.

Pregnancy category C. There are no adequate and well-controlled studies in pregnant women. Trifluridine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Use in lactation: It is unlikely that Trifluridine is excreted in human milk after instillation of Trifluridine eye drops because of the relatively small dosage. The drug should not be prescribed for nursing mothers unless the potential benefits outweigh the potential risks.

Trifluridine should be prescribed only for patients who have a clinical diagnosis of herpetic keratitis.

Use in children: Safety and effectiveness in pediatric patients below 6 years of age have not been established. Use in elderly patients: No overall clinical differences in safety or effectiveness have been observed between elderly and other adult patients.

Ophthalmic Anti-viral Products